|
AVTX
|
Avalo Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AYLA
|
Ayala Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BIOR
|
Biora Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
US
|
NASDAQ
|
|
EXAI
|
Exscientia Limited
|
US
|
NASDAQ
|
|
FUSN
|
Fusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
GH
|
Guardant Health, Inc.
|
US
|
NASDAQ
|
|
GMTX
|
Gemini Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GTH
|
Genetron Holdings Limited
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
US
|
NASDAQ
|
|
INMB
|
INmune Bio Inc.
|
US
|
NASDAQ
|
|
KDNY
|
Chinook Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
POAI
|
Predictive Oncology Inc.
|
US
|
NASDAQ
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
US
|
NASDAQ
|
|
RLAY
|
Relay Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RPTX
|
Repare Therapeutics Inc.
|
US
|
NASDAQ
|
|
STOK
|
Stoke Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PARD3
|
Instituto Hermes Pardini S.A
|
BR
|
SA
|